219
Participants
Start Date
June 13, 2019
Primary Completion Date
April 6, 2020
Study Completion Date
January 15, 2021
PF-06700841
Starting after the Week 16 visit, subjects receiving PF-06700841 10 mg once daily will start to randomly receive either the 60 mg QD dose or 30 mg QD dose until Week 52, as predetermined at randomization. All subjects will receive blinded dosing throughout the 52 weeks study treatment period in order to maintain the study blind.
Placebo
Starting after the Week 16 visit, subjects receiving placebo will start to randomly receive either the 60 mg QD dose or 30 mg QD dose until Week 52, as predetermined at randomization. All subjects will receive blinded dosing throughout the 52 weeks study treatment period in order to maintain the study blind.
"Medical Center Pirogov", Sofia
Qualiclinic Kft., Budapest
"Diagnostic-Consulting Center XVII - Sofia", Sofia
University Multiprofile Hospital for Active Treatment Sveti Ivan Rilski, Sofia
Emeritus Research, Melbourne
MHAT Trimontium OOD, Plovdiv
"University Multiprofile Hospital for Active Treatment Pulmed", Plovdiv
University Multiprofile Hospital for Active Treatment ''Plovdiv'' AD, Plovdiv
Rheumatology Research Unit, Maroochydore
VITAL MEDICAL CENTER Orvosi es Fogorvosi Kozpont, Veszprém
Innomedica OU, Tallinn
Center for Clinical and Basic Research, Tallinn
Institute of Rheumatology, Belgrade
East Tallinn Central Hospital, Tallinn
Hospital Universitario A Coruna, A Coruña
Complejo Hospitalario Universitario de Santiago de Compostela, Santiago de Compostela
Institute for Treatment and Rehabilitation Niska Banja, Niška Banja
Hospital Quironsalud Infanta Luisa, Seville
MEDICAL PLUS s.r.o., Uherské Hradiště
"LLC Family Outpatient clinic #4", Korolyov
State Autonomous Healthcare Institution of Yaroslavl Region, Yaroslavl
"SBHI of the Republic of Karelia Republican Hospital n. a. V.A. Baranov", Petrozavodsk
"Limited Liability Company Sanavita", Saint Petersburg
"FSBEI of HE Ryazan State Medical University n. a academician I.P.Pavlov", Ryazan
"SBI of Ryazan Region Regional Clinical Hospital", Ryazan
"GUZ Regional Clinical Hospital", Saratov
"FGBOU VO Orenburg State Medical University of the Ministry of Health of the Russian Federation", Orenburg
"GBUZ Orenburg Regional Clinical Hospital", Orenburg
"LLC BioMed", Vladimir
L.K.N. Arthrocentrum s.r.o., Hlučín
CCR Czech a.s., Pardubice
Revmatologicky ustav, Prague
CCR Prague s.r.o., Prague
Hospital of Lithuanian University of Health Sciences, Kauno klinikos, Kaunas
National Osteoporosis Center, Vilnius
ZDROWIE Osteo-Medic s.c. L. I A. Racewicz, A. i J. Supronik, Bialystok
ClinicMed Daniluk Nowak Sp. Jawna, Bialystok
"Zespol Poradni Specjalistycznych REUMED Filia nr 2", Lublin
NZOZ Lecznica Mak-Med s.c., Nadarzyn
Twoja Przychodnia - Centrum Medyczne Nowa Sol, Nowa Sól
Ai Centrum Medyczne Sp. z o.o. Sp. k., Poznan
Prywatna Praktyka Lekarska Prof. UM dr hab. med. Pawel Hrycaj, Poznan
RCMed Oddzial Sochaczew, Sochaczew
NASZ LEKARZ Przychodnie Medyczne, Torun
REUMATIKA - Centrum Reumatologii NZOZ, Warsaw
Narodny ustav reumatickych chorob, Piešťany
MUDr. Zuzana Cizmarikova, s.r.o., Poprad
REUMEX s.r.o., Rimavská Sobota
Lead Sponsor
Pfizer
INDUSTRY